88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Regent Pacific (0575.HK)'s Deep Longevity Launches Accrua™ US Consumer Digital Health and Telehealth Platform Available Across All 50 US States, Extending Deep Longevity's AI-Powered Ageing Science Directly to Consumers for a Second Growth Curve ... 2026-09-28T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Lunit Expands AI-Powered Breast Cancer Screening Across the Stockholm Region Following years of clinical validation and proven real-world performance at Saint Göran, Stockholm Region adopts Lunit INSIGHT MMG as an independent second reader at regional scale ... 2026-09-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Heidi II puts agents to work on visit admin, giving clinicians more time with patients Heidi II brings agentic capability into existing clinical workflows, moving from documenting the visit to doing the routine work around it with clinician supervision. ... 2026-09-28T Computer Software Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Link Cell Therapies Initiates Clinical Dosing with Logic-Gated CAR-T Therapy, Expands Executive Leadership, and Upsizes Series A Financing to $90 Million – LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD Anderson Cancer Center – ... 2026-09-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy SAN FRANCISCO and SUZHOU, China , Sept. 28, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, ... 2026-09-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
111, Inc. Announces Establishment of the Special Committee SHANGHAI , Sept. 28, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special ... 2026-09-28T Health Care/Hospital Medical/Pharmaceuticals Retail
SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients TOKYO and BOSTON , Sept. 28, 2026 /PRNewswire/ -- SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), ... 2026-09-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer HONG KONG , Sept. 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a ... 2026-09-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC SAN FRANCISCO and SUZHOU, China , Sept. 28, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, ... 2026-09-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2026 IMS \| IASO Bio Presented FUCASO China Real-World Data - In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients with relapsed/refractory plasma cell neoplasms, FUCASO achieved a 95.9% objective response rate, a 77.2% ... 2026-09-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals